CROs partner on women’s oncology clinical solutions
Health Decisions and OncoBay Clinical will collaborate on specialized clinical development services addressing therapies for women’s cancers.
Health Decisions and OncoBay Clinical will collaborate on specialized clinical development services addressing therapies for women’s cancers.
The company’s cancer drug, devimistat, has received orphan status from the agency for treating clear-cell sarcoma, pancreatic cancer, and other diseases.
Through organizations like the Association of Clinical Research Organizations, clinical research professionals are helping decentralized research evolve.